Browse the detailed record of transactions filed by Deschatelets Pascal, Chief Scientific Officer. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 62 reports have been logged. Breakdown: 0 buy · 20 sells. Total volume traded: €10m. Activity tracked since 24 May 2021. The latest transaction was filed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Deschatelets Pascal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Deschatelets Pascal is Chief Scientific Officer at Apellis Pharmaceuticals, Inc. He has 62 filings in total, and across the sampled recent filings the transactions are sales for EUR 9,979,624 between 2021-05-25 and 2026-05-14, with the transaction nature shown as option exercise.